本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

天演药业

1.53
-0.0500-3.16%
盘后1.530.00000.00%18:25 EDT
成交量:1.23万
成交额:1.95万
市值:7,207.76万
市盈率:-2.06
高:1.66
开:1.66
低:1.50
收:1.58
数据加载中...
2025/03/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC问询函

Form CORRESP - Correspondence
2023/06/16

SEC问询函

Form CORRESP - Correspondence
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/27

关联方拟减持公告

144 - Report of proposed sale of securities
2021/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]